scispace - formally typeset
E

Eli A. Stahl

Researcher at Icahn School of Medicine at Mount Sinai

Publications -  184
Citations -  41968

Eli A. Stahl is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Genome-wide association study & Bipolar disorder. The author has an hindex of 72, co-authored 174 publications receiving 32750 citations. Previous affiliations of Eli A. Stahl include Mount Sinai Hospital & University of Chicago.

Papers
More filters
Journal ArticleDOI

Biological insights from 108 schizophrenia-associated genetic loci

Stephan Ripke, +354 more
- 24 Jul 2014 - 
TL;DR: Associations at DRD2 and several genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses.
Journal ArticleDOI

Genetics of rheumatoid arthritis contributes to biology and drug discovery

Yukinori Okada, +115 more
- 20 Feb 2014 - 
TL;DR: A genome-wide association study meta-analysis in a total of >100,000 subjects of European and Asian ancestries provides empirical evidence that the genetics of RA can provide important information for drug discovery, and sheds light on fundamental genes, pathways and cell types that contribute to RA pathogenesis.
Journal ArticleDOI

Analysis of shared heritability in common disorders of the brain

Verneri Anttila, +720 more
- 22 Jun 2018 - 
TL;DR: It is demonstrated that, in the general population, the personality trait neuroticism is significantly correlated with almost every psychiatric disorder and migraine, and it is shown that both psychiatric and neurological disorders have robust correlations with cognitive and personality measures.
Journal ArticleDOI

Genome-wide association analysis identifies 13 new risk loci for schizophrenia

Stephan Ripke, +79 more
- 01 Oct 2013 - 
TL;DR: The authors conducted a multi-stage genome-wide association study (GWAS) for schizophrenia and found that 8,300 independent, mostly common SNPs (95% credible interval of 6,300-10,200 SNPs) contribute to risk for schizophrenia.